189 related articles for article (PubMed ID: 33089314)
1. Resistance/fitness trade-off is a barrier to the evolution of MarR inactivation mutants in Escherichia coli.
Praski Alzrigat L; Huseby DL; Brandis G; Hughes D
J Antimicrob Chemother; 2021 Jan; 76(1):77-83. PubMed ID: 33089314
[TBL] [Abstract][Full Text] [Related]
2. Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
Praski Alzrigat L; Huseby DL; Brandis G; Hughes D
J Antimicrob Chemother; 2017 Nov; 72(11):3016-3024. PubMed ID: 28962020
[TBL] [Abstract][Full Text] [Related]
3. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.
Vinué L; Corcoran MA; Hooper DC; Jacoby GA
Antimicrob Agents Chemother; 2015 Dec; 60(3):1537-45. PubMed ID: 26711751
[TBL] [Abstract][Full Text] [Related]
4. The 2019 Garrod Lecture: MDR efflux in Gram-negative bacteria-how understanding resistance led to a new tool for drug discovery.
Piddock LJV
J Antimicrob Chemother; 2019 Nov; 74(11):3128-3134. PubMed ID: 31626705
[TBL] [Abstract][Full Text] [Related]
5. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli.
Keeney D; Ruzin A; McAleese F; Murphy E; Bradford PA
J Antimicrob Chemother; 2008 Jan; 61(1):46-53. PubMed ID: 17967850
[TBL] [Abstract][Full Text] [Related]
6. Fitness trade-offs of multidrug efflux pumps in
Liu Y; Van Horn AM; Pham MTN; Dinh BNN; Chen R; Raphael SDR; Paulino A; Thaker K; Somadder A; Frost DJ; Menke CC; Slimak ZC; Slonczewski JL
Appl Environ Microbiol; 2024 Feb; 90(2):e0209623. PubMed ID: 38289137
[TBL] [Abstract][Full Text] [Related]
7. Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB.
Nicoloff H; Perreten V; McMurry LM; Levy SB
J Bacteriol; 2006 Jun; 188(12):4413-23. PubMed ID: 16740948
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics.
Curiao T; Marchi E; Viti C; Oggioni MR; Baquero F; Martinez JL; Coque TM
Antimicrob Agents Chemother; 2015; 59(6):3413-23. PubMed ID: 25824225
[TBL] [Abstract][Full Text] [Related]
9. Improving the organic solvent tolerance of Escherichia coli with vanillin, and the involvement of an AcrAB-TolC efflux pump in vanillin tolerance.
Ikehata Y; Doukyu N
J Biosci Bioeng; 2022 Apr; 133(4):347-352. PubMed ID: 35063375
[TBL] [Abstract][Full Text] [Related]
10. Improvement of organic solvent tolerance by disruption of the lon gene in Escherichia coli.
Watanabe R; Doukyu N
J Biosci Bioeng; 2014 Aug; 118(2):139-44. PubMed ID: 24571965
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of geraniol resistance of Escherichia coli by MarA overexpression.
Shah AA; Wang C; Chung YR; Kim JY; Choi ES; Kim SW
J Biosci Bioeng; 2013 Mar; 115(3):253-8. PubMed ID: 23168261
[TBL] [Abstract][Full Text] [Related]
12. The Atypical Antipsychotic Quetiapine Promotes Multiple Antibiotic Resistance in Escherichia coli.
Kyono Y; Ellezian L; Hu Y; Eliadis K; Moy J; Hirsch EB; Federle MJ; Flowers SA
J Bacteriol; 2022 May; 204(5):e0010222. PubMed ID: 35416690
[TBL] [Abstract][Full Text] [Related]
13. Many chromosomal genes modulate MarA-mediated multidrug resistance in Escherichia coli.
Ruiz C; Levy SB
Antimicrob Agents Chemother; 2010 May; 54(5):2125-34. PubMed ID: 20211899
[TBL] [Abstract][Full Text] [Related]
14. Extreme Acid Modulates Fitness Trade-Offs of Multidrug Efflux Pumps MdtEF-TolC and AcrAB-TolC in Escherichia coli K-12.
Schaffner SH; Lee AV; Pham MTN; Kassaye BB; Li H; Tallada S; Lis C; Lang M; Liu Y; Ahmed N; Galbraith LG; Moore JP; Bischof KM; Menke CC; Slonczewski JL
Appl Environ Microbiol; 2021 Jul; 87(16):e0072421. PubMed ID: 34085861
[TBL] [Abstract][Full Text] [Related]
15. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131.
Atac N; Kurt-Azap O; Dolapci I; Yesilkaya A; Ergonul O; Gonen M; Can F
Curr Microbiol; 2018 Dec; 75(12):1661-1666. PubMed ID: 30283991
[TBL] [Abstract][Full Text] [Related]
16. Lon protease inactivation, or translocation of the lon gene, potentiate bacterial evolution to antibiotic resistance.
Nicoloff H; Andersson DI
Mol Microbiol; 2013 Dec; 90(6):1233-48. PubMed ID: 24325250
[TBL] [Abstract][Full Text] [Related]
17. Roles of Lon protease and its substrate MarA during sodium salicylate-mediated growth reduction and antibiotic resistance in Escherichia coli.
Bhaskarla C; Das M; Verma T; Kumar A; Mahadevan S; Nandi D
Microbiology (Reading); 2016 May; 162(5):764-776. PubMed ID: 26944926
[TBL] [Abstract][Full Text] [Related]
18. Mutations that increase expression of the EmrAB-TolC efflux pump confer increased resistance to nitroxoline in Escherichia coli.
Puértolas-Balint F; Warsi O; Linkevicius M; Tang PC; Andersson DI
J Antimicrob Chemother; 2020 Feb; 75(2):300-308. PubMed ID: 31633764
[TBL] [Abstract][Full Text] [Related]
19. Effect of aminoacyl-tRNA synthetase mutations on susceptibility to ciprofloxacin in Escherichia coli.
Garoff L; Huseby DL; Praski Alzrigat L; Hughes D
J Antimicrob Chemother; 2018 Dec; 73(12):3285-3292. PubMed ID: 30239743
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of RamA, Which Regulates Production of the Multidrug Resistance Efflux Pump AcrAB-TolC, Increases Mutation Rate and Influences Drug Resistance Phenotype.
Grimsey EM; Weston N; Ricci V; Stone JW; Piddock LJV
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
